Cue Biopharma Inc (NAS:CUE)
$ 1.7 0 (0%) Market Cap: 102.35 Mil Enterprise Value: 82.98 Mil PE Ratio: 0 PB Ratio: 3.78 GF Score: 64/100

Cue Biopharma Inc at JMP Securities Life Sciences Conference Transcript

May 15, 2023 / 07:30PM GMT
Release Date Price: $4.45 (+3.49%)
Reni Benjamin
JMP Securities LLC - Managing Director

So good afternoon, everyone. And welcome to the JMP Securities Life Sciences Conference. It's my pleasure to introduce Cue Biopharma. Cue Biopharma is a unique biopharmaceutical company, developing technologies to harness the power of IL-2 in a targeted manner.

And so presenting for the company is Dan Passeri, CEO. Dan, welcome.

Dan Passeri
Cue Biopharma, Inc. - CEO

Thanks, Reni. Thank you. It's good being here.

Questions & Answers

Reni Benjamin
JMP Securities LLC - Managing Director

As I've filled all the CEOs that I'm talking to, I have no idea who's in the audience, let alone who's hitting the replay button. And so, for those who don't know the Cue Biopharma story, can you give us an overview in three to five minutes?

Dan Passeri
Cue Biopharma, Inc. - CEO

Sure. So Cue is basically formed out of the Albert Einstein College of Medicine. And its core competency in the early days of protein

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot